← Leaderboards
Richard Gb Langley
Massachusetts General Hospital
$1,434,712
Attributed
$1,434,712
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,434,712 · 3
By mechanism
M01$1,434,712 · 3
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Harland S Winter$1,653,812
- Shannon K Bromley$5,700,330
- Sanjay K Nigam$28,101,639
- Michael J. Detmar$3,440,302
- Jin Mo Park$8,956,617
Others in their field
Top investigators on “Human Therapy Evaluation”
- Lawrence Corey · Fred Hutchinson Cancer Center$368,153,539
- David Heimbrook · Leidos Biomedical Research, Inc.$241,598,366
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Barbara Driver · Westat, Inc.$206,347,735
- Carol Nesel · Westat$188,148,170
- Constance Ann Benson · University Of California, San Diego$179,950,251
Research focus
Human Therapy EvaluationClinical ResearchHuman SubjectIntravenous AdministrationClinical Trial Phase IPsoriasisCd2 MoleculeImmunotherapyReceptor BindingMonoclonal AntibodySkin Disorder ChemotherapyTopical Drug ApplicationAtopic DermatitisChild (0-11)DosageDosage FormsDrug Screening /EvaluationFk506ImmunomodulatorsPediatric PharmacologyPharmacokineticsAdult Human (21+)
Grant awards (10)
MEDI-507 Monoclonal Antibody in Plaque Psoriasis$200,768
M01 · FY2002 · RR
MEDI-507 Monoclonal Antibody in Plaque Psoriasis$200,768
M01 · FY2002 · RR
MEDI-507 Monoclonal Antibody in Plaque Psoriasis$200,768
M01 · FY2001 · RR
MEDI-507 Monoclonal Antibody in Plaque Psoriasis$0
M01 · FY2001 · RR
SAFETY OF TOPICAL TACROLIMUS OINTMENT FOR PEDIATRIC ATOPIC DERMATITIS PATIENTS$415,629
M01 · FY2000 · RR
DOSE RESPONSE STUDY OF BG9273 IN MODERATE TO SEVERE PLAQUE PSORIASIS$415,629
M01 · FY2000 · RR
DOSE RESPONSE STUDY OF BG9273 IN MODERATE TO SEVERE PLAQUE PSORIASIS$575
M01 · FY2000 · RR
SAFETY OF TOPICAL TACROLIMUS OINTMENT FOR PEDIATRIC ATOPIC DERMATITIS PATIENTS$575
M01 · FY2000 · RR
MEDI-507 Monoclonal Antibody in Plaque Psoriasis$0
M01 · FY2000 · RR
MEDI-507 Monoclonal Antibody in Plaque Psoriasis$0
M01 · FY2000 · RR